Home › Studies › PRJEB91718
PRJEB91718 ERP174654

Gut microbiome in hospitalized COVID-19 patients, Poland

COVID-19 Microbiome - deep samples

383 gut microbiome samples from hospitalized COVID-19 patients in Poland, using shallow and deep shotgun sequencing to track microbiota changes linked to treatment and outcomes; case-control design. machine-written summary

383 samples · 383 runs · PL · Adult · 2025 · 10.05 Gbp / sample

One study deposited as 2 BioProjects (1,329 catalog samples together): PRJEB64515 · PRJEB91718 · show together

Sources
✓Sequence archive 4,242○Abstract / description○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive4,242 sample values (age, antibiotic exposure, bmi, collection date, country, health condition, health condition detail, latitude)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC11219902
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult365
elderly18
Condition
healthy_control141
other_infection97
other_disease73
type2_diabetes47
other_cancer24
colorectal_cancer1
Sex
male147
female95
Country
PL383
Body site
primary383
Collected 2020–2022
2020: 138 samples2021: 222 samples2022: 23 samples20202022
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 1 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 190 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 192 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 10.05 Gbp per sample0130Gbp
! Self-contradictory metadata

antibiotic exposure: two sequence archives disagree for 22 samples (e.g. no vs yes) — withheld.

The sources disagree on 22 samples. Where two incompatible values exist for one sample (or one person's samples disagree on sex), neither value is published: the field is left empty here, in the sample sheet and in the downloads. Both sides, with their sources, are in gut_metadata_contradictions.parquet of the data package (what counts as a contradiction).

Contradicted values (22)
samplefieldvalueother valuehandling
SAMEA118689655antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689658antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689662antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689668antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689670antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689705antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689706antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689707antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689708antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689713antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689717antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689718antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689719antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689743antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689744antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689757antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689758antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689759antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689775antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689776antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689777antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
SAMEA118689823antibiotic exposureno (sequence archive)yes (sequence archive)withheld: neither value published
Sampling design and relatedness

longitudinal

123 of 218 people sampled more than once (288 samples; median 2, up to 3 per person) · follow-up median 6 d (max 39.0 y) · median interval between samples 5 d (time from collection dates). Schedule stated by the source: “Repeated fecal sampling from the same hospitalized patients over time during hospitalization; exact day schedule not stated numerically.” (time origin: admission).

100100: day 0100: day 19100: day 24106k106k: day 0106k: day 1106k: day 2112112: day 0112: day 4112: day 10117k117k: day 0117k: day 1117k: day 2118k118k: day 0118k: day 1118k: day 3119k119k: day 0119k: day 1119k: day 2124k124k: day 0124k: day 1124k: day 2126126: day 0126: day 5126: day 13130k130k: day 0130k: day 2130k: day 4134k134k: day 0134k: day 1134k: day 2140140: day 0140: day 9140: day 13146k146k: day 0146k: day 2146k: day 41717: day 017: day 1096717: day 14237185185: day 0185: day 4185: day 121919: day 019: day 217519: day 911422: day 02: day 82: day 14201201: day 0201: day 5201: day 24250250: day 0250: day 23250: day 30269269: day 0269: day 18269: day 27287287: day 0287: day 9287: day 1533: day 03: day 63: day 23300300: day 0300: day 4300: day 13309309: day 0309: day 4309: day 183131: day 031: day 531: day 153232: day 032: day 032: day 109544: day 04: day 114: day 2246K46K: day 046K: day 146K: day 355: day 05: day 84015: day 1059253k53k: day 053k: day 153k: day 35656: day 056: day 556: day 1166: day 06: day 96: day 156161: day 061: day 761: day 146363: day 063: day 663: day 1375K75K: day 075K: day 175K: day 277K77K: day 077K: day 177K: day 28181: day 081: day 581: day 160 d9.7 y19.5 y29.2 y39.0 y

Each row is one person (36 shown of 123); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 7.4%Bifidobacterium 7.3%Phocaeicola 5.2%Faecalibacterium 4.3%Blautia_A 4.0%Enterococcus_B 3.5%Mediterraneibacter 3.0%Alistipes 3.0%Roseburia 2.8%Klebsiella 2.7%Ruminococcoides 2.7%Escherichia 2.6%not assigned to a genus 8.3%other genera 43.3%

Genera, mean relative abundance over 29 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category383 100%
country383 100%383
health_condition383 100%383
subject_id383 100%383
collection_date383 100%383
detailed_location383 100%
health_condition_detail383 100%383
latitude383 100%383
location_region383 100%383
longitude383 100%383
antibiotic_exposure361 94%361
sex242 63%242
bmi239 62%239
smoking_status169 44%169
medication132 34%132
age_at_collection_days35 9%35
Papers (1)
  • Gut microbiome dynamics and predictive value in hospitalized COVID-19 patients: a comparative analysis of shallow and deep shotgun sequencing. 2024 PMID 38962119 PMC11219902 own_data
Details
Archive description

The gut microbiome has been recognized as a key player in various disease conditions, including COVID-19. In this study, we conducted an extensive gut microbiome analysis in 204 COVID-19 patients hospitalized in two large hospitals in Poland. By employing both shallow and deep shotgun sequencing methods, we aimed to track the changes in microbiota composition induced by hospitalization and COVID-19 treatment. We investigated the associations between microbiome alterations and clinical procedures, such as antibiotics administration, and outcomes, including ICU referral and survival. Notably, our study included a larger cohort than previously published works, allowing for robust conclusions. Leveraging machine learning techniques, we explored the microbiome's predictive potential for COVID-19 prognosis and assessed its performance compared to traditional baseline classifiers (sex, age, BMI). Additionally, we evaluated the feasibility of shallow shotgun sequencing as a cost-effective alternative for diagnostic use in clinical settings. Our findings provide valuable insights into the gut microbiome's role in COVID-19 patients and its potential as a predictive tool for patient outcomes.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.description · “The gut microbiome has been”
  • body site external_curation.infant_catalog · “body_site_call gut”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA118689630age_at_collection_days16436.2R10.85sample.attr.host_age45
SAMEA118689630antibiotic_exposurenoR10.90biosample_attrno
SAMEA118689630bmi26.6R10.90sample.attr.host_body_mass_index26.6
SAMEA118689630collection_date2020-05-12R10.90biosample.attribute:collection_date2020-05-12
SAMEA118689630countryPLR10.90sample.attr.geographic_location_country_and_or_seaPoland
SAMEA118689630health_conditionother_infectionR10.85biosample.attribute:subject_typepatient (case)
SAMEA118689633health_conditionother_cancerR10.85biosample_attryes
SAMEA118689630health_condition_detailnoR10.90sample.attr.diabetes_typeno
SAMEA118689782health_condition_detailpatient (case)R10.85biosample.attribute:subject_typepatient (case)
SAMEA118689630latitude52.2400R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude52.24 21.02
SAMEA118689630location_regionMasovian VoivodeshipR10.60biosample.attribute:geographic_location_latitude+geographic_location_longitude52.24 21.02
SAMEA118689630longitude21.0200R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude52.24 21.02
SAMEA118689636medicationother_medicationR10.90biosample.attribute:other_medicationsyes
SAMEA118689630sexmaleR10.90sample.attr.host_sexmale
SAMEA118689630smoking_statusneverR10.80biosample.attribute:smokerno
SAMEA118689645smoking_statusneverR10.90biosample.attribute:smoking_frequencynever
SAMEA118689630subject_id2R10.85sample.attr.host_subject_id2
Sequencing

383 runs over 383 samples · mean 9.99 Gbp per run (median 10.05 Gbp, total 3,825.36 Gbp; 383 runs with a base count) · layout PAIRED 383 · platform ILLUMINA 383 · models Illumina NovaSeq 6000 (383) · 8% of runs with a Sandpiper profile · first public 2025-07-11

Authors (20)

Kopera K first · Gromowski T · Wydmański W · Skonieczna-Żydecka K · Muszyńska A · Zielińska K · Wierzbicka-Woś A · Kaczmarczyk M · Kadaj-Lipka R · Cembrowska-Lech D · Januszkiewicz K · Kotfis K · Witkiewicz W · Nalewajska M · Feret W · Marlicz W · Łoniewski I · Łabaj PP · Rydzewska G · Kosciolek T last

Downloads

PRJEB91718.csv.gz (11.6 KB) · parquet (88.1 KB) — all 383 samples, every field with route and confidence · PRJEB91718_determinations.csv.gz (30.2 KB) — 4,242 evidence rows

Samples (383 · every field this project has values for · hover a cell for its source)
Loading the sample table…